German sciences and pharma company Merck KGaA (MRK: DE) has launched in partnership with United Nations Educational, Scientific and Cultural Organization (UNESCO) the first edition of the UNESCO-Merck Africa Research Summit, to be held in Geneva, Switzerland.
The summit aims to address the vital role of scientific research in the improvement and sustainable development of the African population health, with specific emphasis on how to translate knowledge into action.
“Merck is very pleased to join forces with UNESCO and take together an active role in addressing health challenges and strengthening the role of scientific research in life sciences and medical sciences for Africa," said Stefan Oschmann, vice chairman of the executive board and deputy chief executive of Merck, at the inauguration of the UNESCO-Merck Africa Research Summit. "The summit will bring together researchers from across Africa to discuss the generation, sharing and dissemination of research data with the aim of identifying development opportunities that will contribute to building research capacity, accelerating access to innovative health solutions and sustaining innovation in Africa," he added.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze